[Elsevier] Indirect treatment comparison of durvalumab plus carboplatin/paclitaxel followed by durvalumab plus olaparib versus pembrolizumab plus carboplatin/paclitaxel followed by pembrolizumab as first-line treatment |
|
This post will be closed automatically in 2026-09-19 16:03
Reward10points
|
10
Sex differences in rate and outcomes of endovascular revascularization for chronic limb-threatening ischemia
10
Dynamic event-driven composite optimal impedance control for lower limb exoskeletons using finite-time reinforcement learning
10
Ternary NiCoMn-LDH coupled with metallic NiCoMn-RGO hybrids for efficient electrocatalytic water splitting and photocatalytic organic pollutant degradation
10
Rapid microwave-assisted synthesis of copper nanoclusters for “on-off-on” fluorescent sensor of tert-butylhydroquinone in edible oil
10
MXene/MOF synergy: HKUST-1 integration with TiCT MXene via aqueous hydrothermal synthesis
